title: [Hyperkaliemic paralysis].
authors.forename: B
authors.initials: B
authors.lastname: Mégarbane
authors.forename: L
authors.initials: L
authors.lastname: Etchegoyen
authors.forename: S
authors.initials: S
authors.lastname: Delerme
authors.forename: D
authors.initials: D
authors.lastname: Résière
authors.forename: F
authors.initials: F
authors.lastname: Baud
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D017583:Hemodiafiltration; D006801:Humans; D006947:Hyperkalemia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D007545:Isoproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D011188:Potassium / Q000097:blood; D011782:Quadriplegia / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D017693:Sodium Bicarbonate / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D002316:Cardiotonic Agents; D017693:Sodium Bicarbonate; D007545:Isoproterenol; D011188:Potassium